Cargando…
GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection
Crimean-Congo hemorrhagic fever virus (CCHFV) is an important human pathogen. Limited evidence suggests that antibodies can protect humans against lethal CCHFV disease but the protective efficacy of antibodies has never been evaluated in adult animal models. Here, we used adult mice to investigate t...
Autores principales: | Golden, Joseph W., Shoemaker, Charles J., Lindquist, Michael E., Zeng, Xiankun, Daye, Sharon P., Williams, Janice A., Liu, Jun, Coffin, Kayla M., Olschner, Scott, Flusin, Olivier, Altamura, Louis A., Kuehl, Kathleen A., Fitzpatrick, Collin J., Schmaljohn, Connie S., Garrison, Aura R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620094/ https://www.ncbi.nlm.nih.gov/pubmed/31309159 http://dx.doi.org/10.1126/sciadv.aaw9535 |
Ejemplares similares
-
Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis
por: Smith, Darci R., et al.
Publicado: (2019) -
The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice
por: Golden, Joseph W., et al.
Publicado: (2022) -
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models
por: Garrison, Aura R., et al.
Publicado: (2017) -
A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice
por: Suschak, John J., et al.
Publicado: (2021) -
Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease
por: Garrison, Aura R., et al.
Publicado: (2019)